Reuters logo
BRIEF-Shanghai Kaibao Pharmaceutical unit receives GMP certificate
February 10, 2017 / 8:35 AM / 10 months ago

BRIEF-Shanghai Kaibao Pharmaceutical unit receives GMP certificate

Feb 10 (Reuters) - Shanghai Kaibao Pharmaceutical Co Ltd :

* Says its wholly owned subsidiary received goods manufacture practice (GMP) certificate from Henan Food and Drug Administration

* Says the certificate issued to chinese herbal medicine manufactured by the subsidiary and the valid period is until Jan. 22, 2022

Source text in Chinese: goo.gl/mqpnyo

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below